Sensitized renal transplant recipients: current protocols and future directions
Authors:
- 16 March 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 6 (5) , 297-306
Abstract
The identification of suitable donor kidneys for transplant candidates with high levels of circulating antibodies against human leukocyte antigen (HLA) is a major challenge and results in prolonged waiting times for transplantation. Technological advances in antibody characterization have permitted a more comprehensive assessment of anti-HLA antibody activity, as well as providing new insights into the clinical effect of HLA antibody class and specificity. Protocols have been developed that enable successful transplantation in patients with donor-specific antibodies (anti-HLA antibodies reactive against their donors). These protocols provide satisfactory early to intermediate-term allograft survival, and constitute an important advance in transplantation. Nevertheless, acute antibody-mediated rejection (AMR) remains a significant challenge, occurring in 20-50% of antibody-incompatible kidney transplantations. Although therapy directed toward lowering donor-specific antibody activity seems to be successful in reversing acute AMR, this condition still has an important negative impact on allograft survival. In addition, subclinical AMR seems to complicate a substantial proportion of positive-crossmatch transplantations even in the absence of allograft dysfunction, and may result in chronic histological abnormalities and shortened allograft function. New interventions for preventing acute AMR, such as anti-C5 antibody-mediated complement blockade and proteasome inhibitor-mediated plasma cell depletion, are promising therapeutic avenues currently under investigation.Keywords
This publication has 108 references indexed in Scilit:
- Intravenous Immunoglobulin a Natural Regulator of Immunity and InflammationTransplantation, 2009
- Naturally occurring interference in Luminex® assays for HLA–specific antibodies: Characteristics and resolutionHuman Immunology, 2009
- Identification of a receptor required for the anti-inflammatory activity of IVIGProceedings of the National Academy of Sciences, 2008
- Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific AntibodiesClinical Journal of the American Society of Nephrology, 2008
- 14th International HLA and Immunogenetics Workshop: Report on understanding antibodies in transplantationTissue Antigens, 2007
- The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant PatientsAmerican Journal of Transplantation, 2007
- The Effect of Desensitization Protocols on Human Splenic B-Cell Populations In VivoAmerican Journal of Transplantation, 2007
- Role of Flow Cytometry to Define Unacceptable HLA Antigens in Lung Transplant Recipients with HLA-Specific AntibodiesTransplantation, 2006
- HLA Antibody Identification With Single Antigen Beads Compared To Conventional MethodsHuman Immunology, 2005
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999